Hossam Abdalla: Lists new updates in COPD 2027 (GOLD) on X
The pulmonology and sleep medicine specialist summarised five points he described as new updates in the 2027 GOLD COPD document.
“Group A: start with a LAMA”— Dr.Hossam Abdalla
Hossam Abdalla, a pulmonology, critical care and sleep medicine specialist who lists membership of the European Sleep Research Society (ESRS) in his profile, posted a short summary of what he called "New Updates in COPD 2027 (GOLD)" on X.
According to his post, the updates are:
- Pre-COPD and PRISm: people in these categories are described as at risk and to be monitored.
- The fixed ratio of below 0.7 stays, with repetition if the value is between 0.6 and 0.8.
- CT once in every COPD patient, if available.
- Group A: start with a long-acting muscarinic antagonist (LAMA).
- New biologics: astegolimab and tozorakimab.
The post also included two linked images.
Original source
“Group A: start with a LAMA”
— Dr.Hossam Abdalla View the post on X